Effects of desloratadine, diphenhydramine, and placebo on driving performance and psychomotor performance measurements

IntroductionFirst-generation antihistamines taken for relief of allergic rhinitis are sedating and pose potential risks for those driving a car or operating machinery. Desloratadine is a potent, selective, histamine H1-receptor antagonist that does not easily cross the blood–brain barrier. It is nonsedating at therapeutic doses and should not affect driving or psychomotor performance.ObjectiveThis study compared the acute effects of desloratadine with diphenhydramine (active control) and placebo on the performance of healthy subjects evaluated with standard over-the-road driving tests (primary objective). The subjects’ performances were also evaluated (secondary objective) with the use of conventional performance tests.MethodsEighteen men and women received a single dose of desloratadine 5 mg, diphenhydramine 50 mg, or placebo during each period of this randomized, double-blind, three-way, crossover study. Two hours post-dosing, subjects operated a specially instrumented vehicle in a 90-min test designed to measure their ability (1) to maintain constant speed and lateral position while following another vehicle at a constant distance and (2) to respond to brake signals. Additionally, a full battery of performance tests was administered.ResultsNo significant differences were noted between desloratadine and placebo in standard deviation of lateral position (SDLP), whereas diphenhydramine treatment significantly increased SDLP (P<0.001 for both comparisons). Brake reaction time was significantly faster following treatment with desloratadine than diphenhydramine (473.72 ms vs 541.22 ms; P<0.001) or placebo (512.06 ms; P=0.033). No differences were seen among treatments in deviation of speed or distance to the lead car. The majority of performance tests showed no significant differences among groups.ConclusionDesloratadine at a therapeutic dose does not impair driving performance.

[1]  J F O'Hanlon,et al.  Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989‐94 , 1995, Allergy.

[2]  E. Volkerts,et al.  Specific review of the psychometric effects of cetirizine , 1995, Allergy.

[3]  F. Simons,et al.  Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis. , 2003, The Journal of allergy and clinical immunology.

[4]  J. F. O'Hanlon,et al.  Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving , 2004, European Journal of Clinical Pharmacology.

[5]  G S Watson,et al.  Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa driving simulator. , 2000, Annals of internal medicine.

[6]  G. Kay,et al.  Impact of sedating antihistamines on safety and productivity. , 2001, Allergy and asthma proceedings.

[7]  J. Hey,et al.  Preclinical Pharmacology of Desloratadine, a Selective and Nonsedating Histamine H1 Receptor Antagonist , 2000, Arzneimittelforschung.

[8]  P. Marshall,et al.  Effects of seasonal allergic rhinitis on selected cognitive abilities. , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[9]  J M Mol,et al.  Standardization in platform stabilometry being a part of posturography. , 1983, Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression.

[10]  J F O'Hanlon,et al.  Diazepam impairs lateral position control in highway driving. , 1982, Science.

[11]  E. Schenkel,et al.  Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis , 2001, Allergy.

[12]  J. O'hanlon,et al.  Effects of mefloquine alone and with alcohol on psychomotor and driving performance , 1996, European Journal of Clinical Pharmacology.

[13]  J. Pickova The Measurement and Appraisal of Adult Intelligence , 1959 .

[14]  Robert Kane,et al.  Decrements in vigilance and cognitive functioning associated with ragweed-induced allergic rhinitis. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[15]  L. Klimek,et al.  Sedation in allergic rhinitis is caused by the condition and not by antihistamine treatment , 1996, Allergy.

[16]  O'Hanlon Jf Antihistamines and driving safety. , 1988 .

[17]  G. Scadding Desloratadine in the Treatment of Nasal Congestion in Seasonal Allergic Rhinitis , 2002 .

[18]  F. Verhey,et al.  A comparative study of the effects of carbamazepine and the NMDA receptor antagonist remacemide on road tracking and car-following performance in actual traffic , 2002, Psychopharmacology.

[19]  Marcelline Burns,et al.  THE EFFECTS OF ALCOHOL AND VALIUM, SINGLY AND IN COMBINATION, UPON DRIVING-RELATED SKILLS PERFORMANCE , 1977 .

[20]  John R Bloomfield,et al.  Effects of Fexofenadine, Diphenhydramine, and Alcohol on Driving Performance , 2000, Annals of Internal Medicine.

[21]  H. R. Jex,et al.  A ``Critical'' Tracking Task for Manual Control Research , 1966 .

[22]  W. Silverman "PRECLINICAL" AND "CLINICAL" EVIDENCE , 1968, Pediatrics.

[23]  D De Waard,et al.  Acute and subchronic effects of the H1-histamine receptor antagonist ebastine in 10, 20 and 30 mg dose, and triprolidine 10 mg on car driving performance. , 1993, British journal of clinical pharmacology.

[24]  J. Hey,et al.  Preclinical Pharmacology of Desloratadine, a Selective and Nonsedating Histamine H1 Receptor Antagonist2nd Communication: Lack of central nervous system and cardiovascular effects , 2000, Arzneimittelforschung.

[25]  W. Dement,et al.  Quantification of sleepiness: a new approach. , 1973, Psychophysiology.

[26]  Kay Gg,et al.  Impact of sedating antihistamines on safety and productivity. , 2001 .

[27]  C. Bachert,et al.  Desloratadine in the Treatment of Seasonal Allergic Rhinitis , 2002 .

[28]  E. Volkerts,et al.  Does cetirizine belong to the new generation of antihistamines? An investigation into its acute and subchronic effects on highway driving, psychometric test performance and daytime sleepiness , 1992 .

[29]  F. Simons,et al.  Clinical Pharmacology of New Histamine H1 Receptor Antagonists , 1999, Clinical pharmacokinetics.

[30]  J. O'hanlon,et al.  Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performance. , 1998, The Journal of allergy and clinical immunology.

[31]  J F O'Hanlon,et al.  Antihistamines and driving safety. , 1988, Cutis.

[32]  M. Ross Quillian,et al.  Retrieval time from semantic memory , 1969 .

[33]  E. Meltzer,et al.  Efficacy and Tolerability of Once-Daily 5mg Desloratadine, an H1-Receptor Antagonist, in Patients with Seasonal Allergic Rhinitis , 2001 .

[34]  L. Salmun,et al.  24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139] , 2002, BMC family practice.

[35]  F. Estelle,et al.  H1-receptor antagonists: safety issues. , 1999, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[36]  Samir K. Gupta,et al.  Desloratadine Demonstrates Dose Proportionality in Healthy Adults After Single Doses , 2002, Clinical pharmacokinetics.